Journal of Veterinary Internal Medicine (Sep 2023)

Prevalence of antibiotic use for dogs and cats in United States veterinary teaching hospitals, August 2020

  • Amanda L. Beaudoin,
  • Emma R. Bollig,
  • Brandy A. Burgess,
  • Leah A. Cohn,
  • Stephen D. Cole,
  • Jonathan D. Dear,
  • Claire L. Fellman,
  • Erin Frey,
  • Robert Goggs,
  • Andrea Johnston,
  • Amanda J. Kreuder,
  • Kate S. KuKanich,
  • Tessa E. LeCuyer,
  • Julie Menard,
  • Krystle L. Reagan,
  • Jane E. Sykes,
  • Julia K. Veir,
  • Katrina Viviano,
  • Annie Wayne,
  • Jennifer L. Granick

DOI
https://doi.org/10.1111/jvim.16814
Journal volume & issue
Vol. 37, no. 5
pp. 1864 – 1875

Abstract

Read online

Abstract Background Awareness of prescribing practices helps identify opportunities to improve antibiotic use (AU). Objectives To estimate AU prevalence in dogs and cats in U.S. veterinary teaching hospitals (VTHs) and identify antibiotic drugs commonly prescribed, indications for use, and evidence of bacterial infection. Animals Medical record data were collected from dogs and cats examined at 14 VTHs. Methods Data were collected from VTH medical records of dogs and cats examined by primary care, urgent care, emergency and critical care, internal medicine, and surgery services on a single day during August 13‐September 3, 2020. Data included signalment; clinical service; inpatient or outpatient status; clinical conditions; diagnostic tests; evidence of bacterial infection; intended reason for AU; name and route of antibiotics prescribed. Results Of 883 dogs and cats, 322 (36.5%) were prescribed at least 1 antibiotic. Among 285 antibiotics administered systemically intended for treatment of infection, 10.9% were prescribed without evidence of infection. The most common class of antibiotics presribed for systemic administration was potentiated penicillin for dogs (115/346, 33.3%) and cats (27/80, 33.8%). For dogs and cats, first‐generation cephalosporins (93/346, 26.9% and 11/80, 13.8%, respectively) and fluoroquinolones (51/346, 14.7% and 19/80, 23.8%, respectively) was second or third most‐prescribed. Common AU indications included skin, respiratory, and urinary conditions, and perioperative use. Conclusions and Clinical Importance Collaborative data collection provides a sustainable methodology to generate national AU prevalence estimates and bring attention to areas requiring additional research and detailed data collection. These efforts can also identify practice improvement opportunities in settings where future veterinarians are trained.

Keywords